Twist Bioscience Corporation provided earnings guidance for the third quarter and fourth quarter of fiscal year 2024. For the third quarter, the company expects total revenue of approximately $77 million.

For the fourth quarter, the company expects total revenue in the range of $77 million to $80 million.